My thinking is that after investing $400,000 into this product, they would not want to see it slip away to a competitor on the basis of successful human trials.
After all, this is a potentially transformative product for TNP therapies.
CZD Price at posting:
4.5¢ Sentiment: Buy Disclosure: Held